Measuring Oncological Value of Exercise and Statin

The aim of the study is to find out whether supervised physical exercise during cancer drug treatment improves the effectiveness of the treatment in metastasized breast, kidney, ovarian and prostate cancer compared to unsupervised exercise. In addition, the investigators are investigating whether the use of atorvastatin combined with guided group exercise training would further improve the response to cancer treatment.

Trial Details

NCT ID
NCT05796973
Phase
PHASE3
Sponsor
Tampere University Hospital
Status
RECRUITING
Cancer Type
Kidney Cancer
Interventions
  • Guided physical exercise
  • Atorvastatin
  • Independent exercise
Locations (sample)
  • Tampere, Länsi-Suomi, Finland|61.49911,23.78712

Key Eligibility Criteria

  • The patient has metastatic prostate cancer, breast cancer, ovarian cancer or kidney cancer confirmed histologically and by imaging, for which 1st-l…
  • Prostate cancer: First course of docetaxel treatment or second-generation antiandrogen treatment for metastatic prostate cancer.
  • Breast cancer: First-line medical treatment of metastatic breast cancer regardless of hormone receptor status.
  • Kidney cancer: Kidney cancer, for which 1st-line cancer drug treatment is started as tki monotherapy and/or IO monotherapy or as a combination ther…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Kidney Cancer Trials on Trialify →